Latest News - Bausch+Lomb

Friday, December 15, 2017 | Miscellaneous, Bausch+Lomb

In Letter to Customers, B+L Reviews Innovations, Preview What's Next

Chuck Hess, Vice President & General Manager, U.S. Surgical, Bausch + Lomb, sent the following letter to customers reviewing some of the innovations the company introduced in 2017, and previewing …

Read the full story

Thursday, November 16, 2017 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Reports Over 1 Million Units of Contact Lens Materials Recycled on First Anniversary of One By One Recycling Program

Bausch + Lomb announced on "America Recycles Day" that its exclusive ONE by ONE recycling program has recycled a combined total of more than one million used contact lenses, blister packs, a…

Read the full story

Tuesday, November 14, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Launches Expanded Parameters of Bausch + Lomb Ultra for Astigmatism Contact Lenses

Bausch + Lomb announced the launch of expanded parameters of Bausch + Lomb ULTRA for Astigmatism contact lenses. This expansion will extend the lens parameter offering to +6.00D to -9.00D in 0.25D ste…

Read the full story

Wednesday, November 08, 2017 | Earnings & Financials, Bausch+Lomb, Valeant

Valeant Profit Beats on Bausch & Lomb Strength

Valeant Pharmaceuticals reported a better-than-expected quarterly profit on strength in its Bausch and Lomb eye-care business, and the Canadian drugmaker maintained its full-year adjusted earnings for…

Read the full story

Tuesday, November 07, 2017 | Conferences, Bausch+Lomb

Three Interactive Exhibits Showcase Bausch + Lomb’s Innovations at AAO

Bausch + Lomb announced that it will feature three interactive exhibits during the Annual Meeting of the American Academy of Ophthalmology (AAO) at the Ernest N. Morial Convention Center in New Orlean…

Read the full story

Thursday, November 02, 2017 | FDA Approval/Clearance, Bausch+Lomb, Nicox , Valeant

Bausch + Lomb And Nicox Announce FDA Approval of Glaucoma Treatment Vyzulta

Bausch + Lomb and Nicox announced that the FDA has approved Vyzulta (latanoprostene bunod ophthalmic solution 0.024%), indicated for the reduction of IOP in patients with open-angle glaucoma or o…

Read the full story

Wednesday, November 01, 2017 | Conferences, Bausch+Lomb

B+L Details New Innovations and Experiences at AAO

Bausch + Lomb Vice President & General Manager, U.S. Surgical, Chuck Hess, distributed the following letter to customers highlighting the company's latest innovations and activities planned fo…

Read the full story

Tuesday, October 31, 2017 | Management/Leadership, Bausch+Lomb

Former Bausch + Lomb CEO Dan Gill Has Died

A longtime former leader of Bausch + Lomb has died, according to a report on WXXI.org. Dan Gill, 81, who was CEO from 1981 to 1995, died on October 27, according to an obituary in the Democrat &…

Read the full story

Tuesday, October 24, 2017 | FDA Approval/Clearance, Bausch+Lomb

Bausch + Lomb Receives 510(k) Clearance from FDA on New 3.3 Software for Victus Femtosecond Laser

Bausch + Lomb announced it has received 510(k) clearance from the FDA for a new 3.3 software package and new hardware for the Victus femtosecond laser platform, which together are designed to enhance …

Read the full story

Monday, October 16, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Envista MX60E IOL

Bausch + Lomb announced the introduction of the enVista MX60E with StableFlex technology, the company's next-generation hydrophobic acrylic lens. The enVista MX60E features AccuSet haptics, whi…

Read the full story

Wednesday, October 04, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Biotrue ONEday for Astigmatism Contact Lenses in Europe

Bausch + Lomb announced the introduction of Biotrue ONEday for Astigmatism daily disposable contact lenses in 20 countries in Europe. This latest contact lens advancement provides the convenience of a…

Read the full story

Wednesday, September 06, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Ocuvite Eye Vitamin Adult 50+ Formula Minigels

Bausch + Lomb announced the launch of Ocuvite Adult 50+ Formula Minigel daily eye vitamins that help replenish vital nutrients that eyes can lose as they age, according to a company news release. The …

Read the full story

Wednesday, August 16, 2017 | Miscellaneous, Bausch+Lomb, Valeant

FDA: Inspection Issues at Bausch + Lomb Manufacturing Plant in Tampa Facility are Being Resolved

Valeant announced that the FDA confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection classification for its Bausch + Lomb manufacturing facility in Tampa. With this confirmation,…

Read the full story

Wednesday, August 09, 2017 | FDA Approval/Clearance, Bausch+Lomb

Bausch + Lomb Receives FDA 510(k) Clearance for the Therapeutic Use of Boston XO and Boston XO2 Materials

Bausch + Lomb announced it has received 510(k) clearance from the FDA for the therapeutic use of its Boston XO and Boston XO2 materials in treating several ocular surface diseases. The Boston XO and B…

Read the full story

Monday, August 07, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Launches Stellaris Elite for Retina Surgery

Bausch + Lomb announced the US launch of the Stellaris Elite vision enhancement system for retina surgery. This new system features multiple advancements as well as the ability to seamlessly integrate…

Read the full story
Load More